Kambiz Yazdi
Stock Analyst at BTIG
(4.50)
# 273
Out of 5,154 analysts
18
Total ratings
66.67%
Success rate
26.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Reiterates: Buy | $58 | $35.93 | +61.42% | 4 | Mar 2, 2026 | |
| VTVT vTv Therapeutics | Maintains: Buy | $40 → $49 | $35.22 | +39.13% | 2 | Jan 27, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $507 → $843 | $310.71 | +171.31% | 5 | Dec 29, 2025 | |
| RAPP Rapport Therapeutics | Reiterates: Buy | $47 | $30.24 | +55.42% | 2 | Dec 8, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $17.31 | +32.87% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $24.00 | -20.83% | 2 | Mar 11, 2025 | |
| EYPT EyePoint | Initiates: Buy | $15 | $15.75 | -4.76% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.64 | +204.88% | 1 | Apr 12, 2024 |
Sionna Therapeutics
Mar 2, 2026
Reiterates: Buy
Price Target: $58
Current: $35.93
Upside: +61.42%
vTv Therapeutics
Jan 27, 2026
Maintains: Buy
Price Target: $40 → $49
Current: $35.22
Upside: +39.13%
Praxis Precision Medicines
Dec 29, 2025
Maintains: Buy
Price Target: $507 → $843
Current: $310.71
Upside: +171.31%
Rapport Therapeutics
Dec 8, 2025
Reiterates: Buy
Price Target: $47
Current: $30.24
Upside: +55.42%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $17.31
Upside: +32.87%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $24.00
Upside: -20.83%
EyePoint
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $15.75
Upside: -4.76%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.64
Upside: +204.88%